Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242517 | SCV000301560 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000297784 | SCV000448737 | uncertain significance | Aspartylglucosaminuria | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000297784 | SCV001031448 | benign | Aspartylglucosaminuria | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004619233 | SCV005119507 | likely benign | Inborn genetic diseases | 2024-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000297784 | SCV001461151 | likely benign | Aspartylglucosaminuria | 2020-04-16 | no assertion criteria provided | clinical testing |